Rex C. Haydon to Tretinoin
This is a "connection" page, showing publications Rex C. Haydon has written about Tretinoin.
Connection Strength
0.587
-
Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. Clin Cancer Res. 2002 May; 8(5):1288-94.
Score: 0.203
-
All-trans retinoic acid inhibits tumor growth of human osteosarcoma by activating Smad signaling-induced osteogenic differentiation. Int J Oncol. 2012 Jul; 41(1):153-60.
Score: 0.101
-
Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLoS One. 2010 Jul 30; 5(7):e11917.
Score: 0.090
-
Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma. Clin Cancer Res. 2010 Apr 15; 16(8):2235-45.
Score: 0.088
-
Retinoic acid signalling induces the differentiation of mouse fetal liver-derived hepatic progenitor cells. Liver Int. 2009 Nov; 29(10):1569-81.
Score: 0.084
-
Activation of RXR and RAR signaling promotes myogenic differentiation of myoblastic C2C12 cells. Differentiation. 2009 Nov; 78(4):195-204.
Score: 0.021